Back to FDA Applications sponsored by ANACOR PHARMS INC

FDA Drug Application 204427 by ANACOR PHARMS INC

Application Number204427
Application Type New Drug Application
Sponsor ApplicantANACOR PHARMS INC
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type New molecular entity (NME)
Therapeutic Potential Standard
Orphan Code 


  
Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP07/7/2014N39798000   http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204427s000lbl.pdf 7/8/2014
AP07/7/2014N39813000   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/204427Orig1s000ltr.pdf 7/9/2014
AP07/7/2014N40155000   http://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/204427Orig1s000TOC.cfm 8/5/2014
AP07/7/2014N40156000   http://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/204427Orig1s000SumR.pdf 8/5/2014
AP01/20/2015SCM       
AP012/15/2014SCM       
AP02/27/2015SLR41976003   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/204427Orig1s003ltr.pdf 3/2/2015
AP02/27/2015SLR42015003   http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/204427s003lbl.pdf 3/4/2015
AP06/26/2015SCM       
AP012/14/2015SCM       




Back to FDA Applications sponsored by ANACOR PHARMS INC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.